# Sandymount Therapeutics Ltd

## Details

- **Company number:** [13514842](https://find-and-update.company-information.service.gov.uk/company/13514842)
- **Status:** Active
- **Type:** Private Limited Company
- **Incorporated:** 16 Jul 2021
- **Registered office:** HAYAKAWA BUILDING,, EDMUND HALLEY ROAD, OXFORD, OX4 4GB
- **Nature of business:** [72110](/sic/72110) Research and experimental development on biotechnology
- **Corporate group:** [Amgen UK Holdings Limited](/group/21139) (3 companies)



## Officers

| Name | Role | Appointed | Resigned |
|---|---|---|---|
| WALKER, Christopher Paul | director | 30 Dec 2025 | 3 Jul 2026 |



## Control

| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Dark Blue Therapeutics Ltd | ownership-of-shares-75-to-100-percent, voting-rights-75-to-100-percent, right-to-appoint-and-remove-directors | 16 Jul 2021 |  |



## Accounts

| Year ended | Net assets | Employees |
|---|---|---|
| 30 Jun 2025 | £1 | 0 |
| 30 Jun 2024 | £1 | 0 |
| 30 Jun 2023 | £1 | 1 |
| 30 Jun 2022 | £1 | 1 |



## Owned by

Sandymount Therapeutics Ltd → [Dark Blue Therapeutics Ltd](/company/12645831) → [Amgen UK Holdings Limited](/company/16897338)





## Companies at the same address

- [Kleidox Therapeutics Ltd](/company/12998606) (12998606)